Sebi imposes Rs 1.15 cr fine on Syncom Healthcare, officials for flouting market norms

Image
Press Trust of India New Delhi
Last Updated : Aug 30 2019 | 5:25 PM IST

Markets regulator Sebi on Friday imposed a total penalty of Rs 1.15 crore on Syncom Healthcare Ltd and its officials for violation of various markets norms while manipulating issuance of global depository receipts (GDR).

During the investigation between August 2010 and September 2010, Sebi noted that the firm had issued 4.5 million GDR amounting to approximately Rs 96 crore on September 3, 2010.

The regulator found that Vintage FZE was the only entity to have subscribed to 4.5 million GDR and the subscription amount was paid by obtaining loan from European American Investment Bank (EURAM).

The investigation revealed that the loan paid by Vintage was secured by pledge agreement between Syncom and EURAM Bank.

Further, "the arrangement of loan and pledge agreement which resulted in subscription of GDR issue of the company, was not disclosed to the exchanges and company reported misleading news to the stock exchanges which contained information in a distorted manner and might have influenced decision of investors," Sebi said.

Thereby, the scheme of issuance of GDRs was fraudulent.

Also, Syncom provided a false list of GDR subscribers.

The firm and its officials have violated provisions of listing agreement and failed to comply with Securities Contract Regulation Act and Prohibition of Fraudulent and Unfair Trade Practices norms, Sebi said.

Accordingly, Sebi levied a fine of Rs 25 lakh on Syncom Healthcare and Rs 15 lakh each on its officials -- Ajay S Bankda, Jyoti Bankda, Jagadish Prasad Bagaria, Bharat Kumar Doshi, Govind Das Pasari and Avichal Kasliwal.

In a separate order, the Securities and Exchange Board of India (Sebi) also imposed a penalty of Rs 10 lakh on an individual for engaging in non-genuine transactions in the scrip of Moryo Industries Ltd.

Sebi noted that inidividual Badrilal Birla "by engaging in such non-genuine transactions, manipulated the price of the scrip of Moryo and also created a misleading appearance of trade in the scrip.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 30 2019 | 5:25 PM IST

Next Story